Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
The company would compete against: Novo Nordisk: Semaglutide products facing generic competition in 2026 Eli Lilly: Tirzepatide medications with recent price reductions Generic manufacturers: Nine companies pursuing semaglutide biosimilars Other innovators: Companies developing next-generation GLP-1 therapies Market Timeline The timeline for Pfizer's long-acting GLP-1 drug remains unclear, as clinical development and regulatory review could take several years
3 After roughly 18 months, participants lost about 10 percent of body weight, and average total testosterone increased by 18 percent, suggesting that weight reduction from GLP-1 therapy may help reverse obesity-related low testosterone
Heres How to Support Your Body Even if youre using a GLP-1 medication, the habits you build matter
[PubMed] [Google Scholar] 36.Baruchel S., Viau G., Olivier R., Bounous G., Wainberg M
US$ 23.64
US$ 24.54
.webp)
US$ 28.09
US$ 20.36
US$ 21.78
US$ 20.77
US$ 20.62
